Oded Edelheit, M.Sc. Ph.D.
Affiliations: | Sackler School of Medicine | Tel Aviv University, Tel Aviv-Yafo, Tel Aviv District, Israel |
Area:
Molecular GeneticsWebsite:
http://www.progen.co.il/Google:
"Oded Edelheit"Mean distance: 10.65 | S | N | B | C | P |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kamal M, Tarcic G, Dureau S, et al. (2018) Revisited analysis of a SHIVA01 trial cohort using functional mutational analyses successfully predicted treatment outcome. Molecular Oncology |
| Peled N, Roisman LC, Miron B, et al. (2017) Sub-Clonal Therapy by two EGFR TKIs Guided by Sequential Plasma Cell-free DNA in EGFR-mutated Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer |
| Loree JM, Miron B, Holla V, et al. (2017) Not all RAS mutations created equal: Functional and clinical characterization of 80 different KRAS and NRAS mutations. Journal of Clinical Oncology. 35: 3589-3589 |
| Miron B, Tarcic G, Edelheit O, et al. (2017) Abstract LB-041: Novel platform to profile variants of uncertain significant (VUS) with preliminary retrospective clinical validation in non-small cell lung cancer (NSCLC) Cancer Research. 77 |
| Tarcic G, Le Tourneau C, Kamal M, et al. (2017) Retrospective analysis of a SHIVA01 trial cohort using functional mutational analysis successfully predicted treatment outcome Annals of Oncology. 28: v450-v451 |
| Tarcic G, Peled N, Barbash Z, et al. (2016) Functional profiling of oncogenic mutations in lung cancer patients (NCT02274025): Interim results. Journal of Clinical Oncology. 34: e20066-e20066 |
| Sullivan RJ, Barbash Z, Edelheit O, et al. (2016) Functional characterization of non-V600 BRAF mutations and their response to Trametinib (Tram). Journal of Clinical Oncology. 34: 9537-9537 |
| Tarcic G, Simon DA, Jacobstein M, et al. (2016) Functional characterization of VUS mutations found in patients' cell-free circulating tumor DNA (ctDNA) using Precision Cancer Analysis System (PCAS). Journal of Clinical Oncology. 34: 11576-11576 |
| Miron B, Peled N, Barbash Z, et al. (2016) Functional characterization of mutations and their interaction using the novel functional annotation for cancer treatment (FACT) platform Annals of Oncology. 27: vi404 |
| Tarcic G, Kamal M, Edelheit O, et al. (2016) Functional mutational analysis to assess the oncogenic activity of variant of uncertain significance (VUS) detected in patients included in the SHIVA trial European Journal of Cancer. 69: S6-S7 |